WELLS FARGO & COMPANY/MN - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 176 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$251,884
-42.1%
11,270
-44.3%
0.00%
Q2 2023$434,915
+19.6%
20,238
+33.5%
0.00%
Q1 2023$363,545
+355.7%
15,154
+340.7%
0.00%
Q4 2022$79,785
+10.8%
3,439
-23.9%
0.00%
Q3 2022$72,000
-14.3%
4,518
-4.9%
0.00%
Q2 2022$84,000
-94.3%
4,751
-93.4%
0.00%
Q1 2022$1,474,000
-14.4%
72,395
-21.4%
0.00%
Q4 2021$1,721,000
-34.5%
92,091
-30.8%
0.00%
-100.0%
Q3 2021$2,626,000
-12.3%
133,006
+5.0%
0.00%0.0%
Q2 2021$2,995,000
-11.4%
126,698
-11.2%
0.00%0.0%
Q1 2021$3,381,000
+53.5%
142,598
+29.6%
0.00%0.0%
Q4 2020$2,203,000
+2.9%
110,013
+7.0%
0.00%0.0%
Q3 2020$2,140,000
+37.1%
102,793
+15.3%
0.00%
Q2 2020$1,561,000
+25.8%
89,190
+17.4%
0.00%
Q1 2020$1,241,000
-4.6%
75,963
+20.2%
0.00%
Q4 2019$1,301,000
+97.4%
63,185
+10.2%
0.00%
Q3 2019$659,000
-2.9%
57,346
+11.0%
0.00%
Q2 2019$679,000
-26.8%
51,649
-15.6%
0.00%
Q1 2019$927,000
-32.7%
61,174
-23.8%
0.00%
Q4 2018$1,377,000
+86.3%
80,270
+60.1%
0.00%
Q3 2018$739,000
+77.6%
50,135
+187.7%
0.00%
Q2 2018$416,000
-11.5%
17,429
-5.3%
0.00%
Q1 2018$470,000
-29.9%
18,406
-73.8%
0.00%
Q4 2017$670,000
+41.1%
70,359
+55.5%
0.00%
Q3 2017$475,000
-5.4%
45,254
+12.8%
0.00%
Q2 2017$502,000
-42.5%
40,118
-53.8%
0.00%
Q1 2017$873,000
+225.7%
86,776
+404.1%
0.00%
Q4 2016$268,000
+56.7%
17,213
+94.2%
0.00%
Q3 2016$171,000
+612.5%
8,865
+350.5%
0.00%
Q2 2016$24,000
-80.8%
1,968
-71.3%
0.00%
Q1 2016$125,000
-20.4%
6,847
+20.1%
0.00%
Q4 2015$157,000
+15600.0%
5,701
+17175.8%
0.00%
Q3 2015$1,000
-83.3%
33
-90.1%
0.00%
Q2 2015$6,0003340.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Rubric Capital Management LP 2,606,500$51,452,0001.44%
Camber Capital Management LP 2,000,000$39,480,0001.22%
Eventide Asset Management 2,629,593$51,908,0000.68%
GREAT POINT PARTNERS LLC 121,342$2,395,0000.56%
RICE HALL JAMES & ASSOCIATES, LLC 753,038$14,865,0000.55%
Values First Advisors, Inc. 41,773$825,0000.53%
CLARK ESTATES INC/NY 183,800$3,628,0000.52%
EMERALD MUTUAL FUND ADVISERS TRUST 710,398$14,023,0000.48%
EMERALD ADVISERS, LLC 590,256$11,652,0000.42%
ACORN FINANCIAL ADVISORY SERVICES INC /ADV 68,812$1,358,0000.42%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders